Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fasttrack5on May 24, 2017 5:19pm

186 Views

Post# 26279679

RE:RE:RE:6 days to go !!!!!

Roger Dumoulin-White concluded: "The company looks forward to successfully reporting out on the first three patients treated in the phase Ib clinical study for NMIBC in late May, 2017. If successful, this will allow the company to significantly derisk its PDT technology and increase shareholder value by successfully transforming from a preclinical to a clinical organization in the field of oncology."

As we wait.

Bullboard Posts

Gold vs. bitcoin, where should you invest?